Today: 19 May 2026
Boeing stock dips after hours as Pentagon awards $2.7 billion Apache support contract
31 December 2025
2 mins read

Boeing stock dips after hours as Pentagon awards $2.7 billion Apache support contract

NEW YORK, December 31, 2025, 5:20 PM ET — After-hours

  • Boeing shares fell about 0.6% in after-hours trading, tracking a weaker finish for U.S. stocks.
  • A Pentagon contract notice showed Boeing won a $2.73 billion Army award for Apache helicopter post-production support.
  • Investors are watching whether defense work can underpin cash flow as Boeing navigates tight FAA oversight of its commercial jet output.

Boeing shares slipped in after-hours trading on Wednesday after a Pentagon contracts notice showed the company won an Army award worth about $2.7 billion tied to Apache helicopter support. Boeing stock was down about 0.6% at $217.12.

The latest award matters because Boeing is leaning on steadier defense work to balance a still-scrutinized commercial jet business. With markets heading into a holiday break, investors have been quick to latch onto any sign of durable revenue and cash generation going into 2026.

A Reuters Breakingviews column noted that roughly a third of Boeing’s revenue comes from its defense, space and security segment, which depends on government contracts. It also pointed to Wall Street price targets implying a 38% rise over the next 12 months, based on Visible Alpha data as of late November.

The Army notice listed the Boeing award at $2,728,234,918 and described it as a firm-fixed-price contract — meaning the price is set and Boeing typically bears more of the cost overrun risk. The work locations and funding will be set with each order under the contract, with an estimated completion date of Dec. 31, 2030.

The Apache support award landed two days after the Pentagon announced an $8.6 billion Boeing contract for the F-15 Israel Program, including 25 new F-15IA jets with an option for 25 more. The Pentagon said contract work would be performed in St. Louis and was expected to be completed by Dec. 31, 2035.

Boeing stock traded between $216.14 and $219.50 during the regular session, LSEG data showed. It closed the year-end session as U.S. indexes fell, with the Dow down 0.63% and the S&P 500 down 0.74%.

Thin holiday volumes helped amplify moves across the tape. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity. Reuters

Boeing’s defense wins also keep the company in the center of Washington’s industrial policy debate. The Breakingviews column argued a U.S. government investment in Boeing would fit a broader push toward “state capitalism,” given Boeing’s role as a major military supplier and exporter. Reuters

At the same time, the commercial side remains a key swing factor for equity investors. Breakingviews said the Federal Aviation Administration limits how many 737 MAX planes Boeing can make and can shape how much autonomy the company has in conducting inspections — oversight that investors see as a gatekeeper for any production rebound.

Competitive pressures remain in the background. Boeing and Airbus dominate large commercial jetmaking — a duopoly, meaning a market led by two players — while Breakingviews highlighted state-backed rivals, noting that the German, French and Spanish governments collectively own about a quarter of Airbus.

Traders now look to the next full session for follow-through, after U.S. stock markets close Thursday for New Year’s Day and reopen Friday. Any fresh Pentagon awards, FAA signals, or company updates on inspections and production will likely be the next headline catalysts for Boeing shares.

For now, Boeing ended the year just below the $220 level it tested during the session, leaving investors to weigh whether the latest defense contract flow can offset lingering uncertainty around commercial output in early 2026.

Stock Market Today

  • Wall Street Falls Amid Rising Inflation Concerns and Bond Yields
    May 19, 2026, 5:43 PM EDT. Wall Street declined on Tuesday as inflation fears intensified, driving long-dated U.S. bond yields to their highest level since 2007. Investors reacted cautiously amid mixed signals regarding U.S.-Iran negotiations, focusing instead on upcoming Nvidia earnings scheduled for Wednesday. Rising bond yields often signal inflation expectations, prompting concerns over potential impacts on equities.

Latest articles

Skillz Stock Jumps 18% as Traders Eye $420 Million Papaya Verdict

Skillz Stock Jumps 18% as Traders Eye $420 Million Papaya Verdict

19 May 2026
Skillz shares rose 18.2% to $7.80 Tuesday, valuing the company near $120 million. Investors focused on a June court decision after a federal jury ordered Papaya Gaming to pay $420 million in damages for false advertising. Skillz reported a first-quarter net loss of $10.9 million on $29.1 million revenue. The court has not finalized the damages award.
CleanSpark rises after Wall Street notes AI power angle

CleanSpark rises after Wall Street notes AI power angle

19 May 2026
CleanSpark shares rose 9.3% to $14.69 late Tuesday after Bernstein highlighted bitcoin miners’ potential as AI data-center power providers. The move outpaced bitcoin and peers, despite CleanSpark’s recent 25% revenue drop and $378.3 million net loss. Bernstein set a $24 target, citing $90 billion in AI-related deals across the sector. CleanSpark reported 1.8 gigawatts under contract and nearly $1.2 billion in liquidity at March 31.
Kraken Robotics Shares Climb as PNG Recovers After TSXV Holiday

Kraken Robotics Shares Climb as PNG Recovers After TSXV Holiday

19 May 2026
Kraken Robotics shares closed up 2.2% at C$7.44 Tuesday, outperforming the TSX Composite’s 0.3% drop. The move followed no new company disclosures, with investors focusing on the pending C$615 million Covelya acquisition and 2026 guidance. Trading volume reached 1.48 million shares. Kraken recently reported 2025 revenue of C$102.2 million and guided 2026 revenue to C$165–175 million.
Meta stock slips after-hours as scam-ad scrutiny mounts, Manus AI deal draws focus
Previous Story

Meta stock slips after-hours as scam-ad scrutiny mounts, Manus AI deal draws focus

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop